Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
Accumulating evidence suggests that metformin reduces the incidence and mortality of colorectal cancer (CRC). However, underlying mechanisms have not been fully clarified. The aim of this study was to examine the pathological characteristics of resected CRC from patients treated with metformin for t...
Saved in:
| Published in: | Cancer science Vol. 111; no. 11; pp. 4012 - 4020 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
John Wiley & Sons, Inc
01.11.2020
John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 1347-9032, 1349-7006, 1349-7006 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!